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INTRODUCTION
Breast cancer death rates are growing around the world due to the chemoresistance and chemo-related side effects. Heterogeneity in breast cancer arises from various cellular and molecular biology of this cancer, as more than 50 different breast cancer cell types are currently developed [1] .
As the result of early studies having been conducted on cell lines of breast cancer, the understanding upon the molecular mechanisms involved in this cancer has been considerably developed [2] .
A source of homogeneous cells with similar molecular characteristics is a valuable tool to evaluate various molecular mechanisms once affected by an external agent [2] . Cell lines could be used as a primary model for predicting the effects of a drug or a plant extract on a particular type of cancer [3] . This cell linebased approach has been widely used in large and small laboratories for the initial and inexpensive evaluation of plant extracts, particularly herbal medicines on various cancerous cells.
Herbal medicine as an imperative branch of complementary and alternative medicine has increasingly grown in the last decade for cancer-related goals [2] , making them a reliable means to increase efficacy and reduce toxicity associated with chemotherapy in different malignancies [1, 4] . Many experiments have demonstrated that natural products can effectively regulate proliferation, differentiation and expression of breast cancer cells in vitro and in vivo [5] .
The present review article is an effort to indicate cytotoxic activity of herbal extracts on the commonly used breast cancer cell lines, MCF7 and SKBR3, introducing the most effective plant extracts for further herbrelated researches and also in vivo experiments. This study has summarized the amount of cytotoxicity, family, used parts and growth region of studied plants.
RESULTS

Literature search
Initial database searches provided 341 eligible articles within the literature for inclusion. Then, we removed 19 duplicate ones and 41 other abstracts, mostly due to a lack of inclusion criteria, and finally the full texts of 281 articles were evaluated, among them 46 articles were excluded after reviewing the full texts, mainly because of IC50 unavailability. Overall, 235 articles in which 192 of them included MCF7 cell line and 43 of them involved SKBR3 cell line data provided the suitability criteria to be reported in this study. Finally, 295 plant extracts have been screened in this review.
Most commonly used breast cancer cell lines in in vitro studies
Initially, our goal was to investigate the effect of plant extracts on all breast cell lines. Therefore, we gathered the list of breast cancer cell lines from ATCC website. Then, we started exploring experiments on these cell lines with the aim of investigating the effect of plant extracts against them. Our findings showed that more than 60% of herb-effected studies have conducted on MCF7 and SKBR3 cell lines ( Figure 1 ). MCF7, as the most commonly used breast cancer cell line, have provided an efficacious in vitro model to study the effectiveness of plant extracts. Therefore, we focused on these two cell lines (MCF7 and SKBR3) to continue our study. 
Cytotoxicity Evaluation
In this study, we evaluated the in vitro cytotoxic activity of 235 medicinal plants against MCF7 and SKBR3 cells. Cytotoxicity was evaluated by the IC50 value. The American National Cancer Institute assigns a limit (IC50 value 20 and 4 µg/ml for 48-72 h incubation, respectively) for the significant cytotoxic effect of a promising anticancer product [6] . Therefore, we investigated plant extracts with IC50<4 μg/ml as the most effective compounds. Accordingly, Cassia garrettiana (IC50: 0.02 μg/ml) presented the highest cytotoxic effect on MCF7 cells, followed by Allium sativum (IC50: 0.12 μg/ml) and Centratherum anthelminticum (L.) Kuntze (IC50: 0.39 μg/ml) and the least cytotoxicity was noticed in Muscari comosum (IC50: 9.13 mg/ml). On the other hand, Garcinia morella Desr (IC50: 2.18 μg/ml) displayed the highest cytotoxic effect on SKBR3 cells which is followed by Phellodendron amurense tree (IC50: 2.5 μg/ml) and Ziziphus jujube (IC50: 3.7 μg/ml) and the least cytotoxicity was observed in Cichorium intybus (IC50: 300 μg/ml).
India has the most researches for the herbal treatment on MCF7 and SKBR3
India has published the highest number of articles (75 articles) in the field of herbal treatment on breast cancer cell lines. Iran (30 articles) and China (17 articles) stand in the second and the third place, respectively.
DISCUSSION
According to plant screening program (US NCI), crude extracts and pure compounds can be considered as cytotoxic agents against cancerous cells if they exhibit IC50 value less than 20 and 4 µg/ml after 48-72 h incubation, respectively [7] . Accordingly, we decided to highlight species with the most cytotoxic effect. Therefore, we investigated plant species with an IC50 value less than 4 µg/ml. in SKBR3 cell line. The effect of nexrutine is related to G1 cell cycle arrest and induction of apoptosis. Other studies have also revealed that nexrutine treatment plays an important role in the inhibition of cell proliferation in various cancers [15] .
Ziziphus jujube (IC50: 3.7 μg/ml)
Ziziphus jujube has been used for curing various diseases such as digestive disorders, weakness, liver complaints, obesity, urinary troubles, diabetes, skin infections, fever, pharyngitis, bronchitis, anemia, diarrhea, insomnia and cancer. The n-hexane (ZE1), chloroform and methanol extracts of Ziziphus jujube fruit have inhibited cell viability by 50% at the concentration of 3.7 µg/ml in SKBR3 cells. The anti-cancer activity of Ziziphus jujube is due to triterpenic acids in the extract. It has also induced apoptosis in SKBR3 breast cancer cells [16] .
Nowadays drug resistance is increasing in cancer cells, making the treatment approaches more complicated. Medicinal herbs with their anti-cancer property could be applied as a complementary drug in treatment of malignancies [17] . Studying the plant extracts helps us recognize their effective compounds. Investigation through molecular mechanism of herbs could lead to identification of intracellular function and also recognition of new targets for cancer treatment [18, 19] .
One of the mechanisms involved in cancerous cells, is the overexpression of HER2 and ER which are highly expressed in SKBR3 and MCF7 [20, 21] . Cassia garrettiana and Phellodendron amurense insert their cytotoxic effect with the least IC50 (2.5 μg/ml and 0.02 μg/ml) on MCF-7 and SKBR3, respectively. The difference between IC50 in MCF-7 and SKBR3 could be related to the difference in expression of HER2 and ER in these cell lines. However, further study is needed for investigation through expression of HER2 and ER. Moreover, a comparison upon the effect of these extracts could demonstrate whether they are effective on HER2 or ER. The assessment of synergistic and antagonistic effect of different plant extracts or their effective compounds could result in discovering new potential anti-cancer combinations [22] .
CONCLUSION
Comparing the impacts of 295 plant extracts having been screened in this review revealed efficacy of 9 plant extracts with IC50 value less than 4 μg/ml for the most cytotoxicity against breast cancer cells, so these extracts can be used for the isolation of their pure components with anti-tumor potential for chemoprevention or cancer treatment. We suggest studying these cytotoxic extracts against other breast cancer cell lines to provide additional data regarding their anti-cancer properties. However, analyzing the effect of these natural products on normal cells is still required to elaborate the effective dose with the least toxic effect. Future studies could focus on the use of different solvents for extraction of the phytochemicals in distinct parts of the plants and finding out new compounds through combining various fractions of these 9 plant extracts to discover more cytotoxic agents with the least adverse effects.
MATERIALS AND METHODS
Studies eligible for review
PubMed and Google Scholar databases were searched using the terms 'plant extract', 'breast cancer', 'breast cancer cell line', 'MCF7 or MCf-7', 'SKBR3 or SKBR-3', 'IC50', 'cytotoxicity' with English language restriction. In animal studies, those which had no effect or did not present their results with IC50 value were excluded. Studies were considered eligible if a) studied cell line was breast cancer (MCF7 and SKBR3); b) treatment substance was one of the plant extract or its derivatives; c) cytotoxicity result was reported in the form of IC50; d) cytotoxicity result was reported in the μg/ml; e) the cytotoxic effect of the extract was investigated using MTT assay, Trypan Blue exclusion assay and Sulforhodamine B (SRB) assay.
Data abstraction
Titles and abstracts of collected articles were screened and the full text of selected literatures were evaluated. The search ended in July 2018. The findings were independently assessed by two of the authors (ND and MD).
The main characteristics of the articles
The selected articles were screened and specific characteristics of the studies were recorded. These characteristics include: plant species and family, type of breast cancer cell line (e.g. MCF7 or SKBR3), used plant part in the study (e.g. root, leaf…), growth region of plant, the kind of effect and IC50 value. This process has been summarized in Table 1 and 2. To minimize selection bias, screening of the studies was independently performed by two of the authors (PM and OY). 
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